Tocilizumab for Acute Chest Syndrome
Tocilizumab for Acute Chest Syndrome
Recruiting · NCT05640271 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tocilizumab for Acute Chest Syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Respiration Disorders, acute chest syndrome, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, lung disorder, respiratory system disorder, sickle cell disease | Recruiting | Phase 2 | 2026-09-15 | NCT05640271 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Chicago | Chicago | United States | 312 |